In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP and Austin Murray with Sykes & Company are talking about all things PBM related with Dared Price from OreadRx.

Join us as we discuss the:

• Urgent need for transparency and reform in the industry
• Intricate world of Pharmacy Benefit Managers (PBMs)
• OreadRx self-sufficient and transparent PBM model
• Opportunities for Growth in Pharmacy

Stay up to date on new episodes by liking and subscribing!

Click here to learn more about our podcast team and previous episodes.

Read and follow along with this episode by clicking here

Schedule an Rx Assessment

More about our guest:

Dared Price is the owner of 7 independent community pharmacy locations in South Central Kansas, Graves Drugs and the Damm Pharmacies. He serves on the board of directors for the National Community Pharmacy Association and is the immediate past president of the Kansas Pharmacist Association. Price is also co-owner of Oread Rx, a transparent, pass through pharmacy benefit company.

Stay connected with Dared Price and OreadRx:

Dared Price LinkedIn

OreadRx Website

OreadRx Facebook

Stay connected with us on social media

Sykes & Company P.A.:

Facebook
Twitter (X)
LinkedIn
Instagram

CPA’s:

Scotty Sykes – CPA, CFP LinkedIn

Scotty Sykes – CPA, CFP Twitter

More resources about this topic:

Podcast – Navigating Pharmacy Reimbursements and Negotiation Strategies

Podcast – Finishing the Fight: What’s Next for Independent Pharmacy

Podcast – The State of PBM Reform

🎉 It’s episode 50 which means it’s time to celebrate a milestone! 🎉

In this milestone episode, Ollin Sykes, CPA, CMA, CITP and Bonnie Bond, CPA are thrilled to sit down with the esteemed Doug Hoey, CEO of the National Community Pharmacists Association (NCPA).

This episode is packed with updates and insights into:

• Payment Reform
• Finish the Fight Campaign
• Advice for Independent Pharmacy Owners in 2024

Join the Discussion with Ollin Sykes, Bonnie Bond, and Doug Hoey!

Schedule an Rx Assessment

Stay up to date on new episodes by liking and subscribing!

Read and follow along with this episode by clicking here for the transcript.

More about our guest:

Douglas Hoey is the Chief Executive Officer of the National Community Pharmacists Association. NCPA represents the owners of nearly 20,000 pharmacy small businesses who’s pharmacists provide prescription dispensing services and help fill primary care gaps. The majority of these pharmacies are located in areas the CDC ranks as “high” or “very high” on the Socially Vulnerable Index. Consumers consistently rank community pharmacies as the top-rated pharmacies in the country.

Hoey is a licensed pharmacist in Oklahoma, Virginia, and Texas and practiced in community pharmacies including his family’s pharmacy before coming to NCPA. He is widely quoted by media as an industry expert on community pharmacy payment and practice issues. Hoey also developed and taught pharmacology courses at George Washington and Marymount universities.

He is President of the World Pharmacy Council, co-Chairman of the Board of Directors for Surescripts, Chairman of the NCPA Innovation Center, and co-Chairman of the CPESN-USA Board.

Want to learn more about Doug Hoey the NCPA and stay connected with them? Check out their social media below:

Doug Hoey LinkedIn

Doug Hoey Twitter (X)

NCPA Website

NCPA Facebook

NCPA Twitter (X)

NCPA LinkedIn

NCPA Instagram

Stay connected with us on social media:

Sykes & Company P.A.:

Facebook
Twitter (X)
LinkedIn
Instagram

CPA’s:

Scotty Sykes – CPA, CFP LinkedIn

Scotty Sykes – CPA, CFP Twitter

Bonnie Bond – CPA LinkedIn

Bonnie Bond – CPA Twitter

More resources about this topic:

Press Release – Sykes & Company, P.A. Joins NCPA’s CORE Program

Webinar – Finish the Fight

Blog – Top 3 Independent Pharmacy Tips for 2024

In this special episode of our tradeshow series, we come to you from 2024 McKesson IdeaShare!

Scotty Sykes, CPA, CFP and Kathy Blanchard, Senior Pharmacy Accountant share trends, insights from their talk at the Deep Dive Labs, and we also bring on Nicolette Mathey, PharmD to do a deep dive into the GLP compounding opportunity for independent pharmacies.

Schedule an Rx Assessment

Stay up to date on new episodes by following our show!

About Nicolette Mathey, PharmD:

Dr. Nicolette Mathey started her career at Walgreens at age 16 and earned her PharmD from the University of Florida in 2010. After pioneering a successful Bedside Delivery program at BayCare Health Systems, she became the Director of Clinical Services at Pharmacy Development Services. There, she co-developed the Clinical Services Profit Ignitor and played a pivotal role in early data analytics. In 2017, Nicolette acquired Palm Harbor Pharmacy, transforming it from a contracts-only establishment in a Heat Zone to a thriving hub. She revamped its identity, introducing robust digital marketing, a multi-rep sales system, compounding, immunizations, NABP accreditation, Test & Treat, Pharmacogenomic (PGX) Testing, and more. In 2019, Nicolette founded ATRIUM24, initially offering business consulting to pharmacies. Focused on developing software to automate data analytics and launch Dotti, the industry’s first CRM sales system tailored for pharmacies, she sold Palm Harbor Pharmacy to another independent owner in October 2023. With the official launch of Dotti in January 2024, Dr. Mathey continues to innovate, aiding pharmacies in maximizing their data for profitability and growth. Through ATRIUM24 and Dotti, she and her team “connect the dots” for sales and marketing initiatives, empowering pharmacies with cutting-edge tools.

Nicolette’s LinkedIn

Atrium24 Website

Atrium24 Facebook

Atrium24 Instagram

Atrium24 LinkedIn

Atrium24 YouTube

Stay connected with us on social media:

Facebook

Twitter (X)

LinkedIn

Instagram

CPA’s:

Scotty Sykes – CPA, CFP LinkedIn

Scotty Sykes – CPA, CFP Twitter

More resources about this topic:

Blog – The Changing Pharmacy Dynamics: Unveiling New Financial Trends for 2024

Blog – Top 3 Independent Pharmacy Accounting Tips for 2024

SERIES – Master the Margin Episode 1: Independent Pharmacy Accounting Fundamentals

Podcast – Navigating the Legal Maze of 503B Compounding